1. Home
  2. LXRX vs FNLC Comparison

LXRX vs FNLC Comparison

Compare LXRX & FNLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • FNLC
  • Stock Information
  • Founded
  • LXRX 1995
  • FNLC 1864
  • Country
  • LXRX United States
  • FNLC United States
  • Employees
  • LXRX N/A
  • FNLC N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • FNLC Major Banks
  • Sector
  • LXRX Health Care
  • FNLC Finance
  • Exchange
  • LXRX Nasdaq
  • FNLC Nasdaq
  • Market Cap
  • LXRX 124.4M
  • FNLC 284.1M
  • IPO Year
  • LXRX 2000
  • FNLC 1999
  • Fundamental
  • Price
  • LXRX $0.36
  • FNLC $24.51
  • Analyst Decision
  • LXRX Buy
  • FNLC
  • Analyst Count
  • LXRX 4
  • FNLC 0
  • Target Price
  • LXRX $3.67
  • FNLC N/A
  • AVG Volume (30 Days)
  • LXRX 9.5M
  • FNLC 19.8K
  • Earning Date
  • LXRX 03-06-2025
  • FNLC 04-16-2025
  • Dividend Yield
  • LXRX N/A
  • FNLC 5.85%
  • EPS Growth
  • LXRX N/A
  • FNLC N/A
  • EPS
  • LXRX N/A
  • FNLC 2.43
  • Revenue
  • LXRX $31,081,000.00
  • FNLC $79,740,000.00
  • Revenue This Year
  • LXRX N/A
  • FNLC N/A
  • Revenue Next Year
  • LXRX $101.91
  • FNLC N/A
  • P/E Ratio
  • LXRX N/A
  • FNLC $10.23
  • Revenue Growth
  • LXRX 2481.48
  • FNLC 0.35
  • 52 Week Low
  • LXRX $0.28
  • FNLC $21.77
  • 52 Week High
  • LXRX $2.62
  • FNLC $31.05
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 32.86
  • FNLC 36.81
  • Support Level
  • LXRX $0.33
  • FNLC $24.34
  • Resistance Level
  • LXRX $0.41
  • FNLC $26.38
  • Average True Range (ATR)
  • LXRX 0.06
  • FNLC 0.55
  • MACD
  • LXRX -0.02
  • FNLC -0.11
  • Stochastic Oscillator
  • LXRX 16.38
  • FNLC 8.33

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

Share on Social Networks: